You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info

Xpert® MRSA/SA SSTI

Detect MRSA & SA Skin and Soft Tissue Infections In About One Hour

Product Resources MyCepheid Store
Xpert<sup>®</sup> MRSA/SA SSTI
#carousel-featured_content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-featured_content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
VIDEO

Catawba Valley Medical Center leverage the GeneXpert® for HAI Testing

Catawba Valley Medical Center, a non-profit, locally controlled community hospital in Hickory North Carolina highlights how they utilize the GeneXpert System throughout the hospital to improve patient care.

Watch Video

Video Image

The Need

SSTIs are a major health concern

  • The most common cause of skin and soft tissue infections is Staph aureus; MRSA represents over 50% of these infections in parts of the U.S.1
  • Current laboratory methods can take up to 72 hours to determine if a SSTI is SA or MRSA
  • Empiric treatment, found to be incorrect in 57% of patients according to one study, is employed due to lack of a rapid identification method2

(1) CDC. CDC Steps Up Efforts to Fight Drug-Resistant Germ. Press Release. 2008 Sep 8. Accessed May 2020.
(2) Moran, GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006 Aug 17;355(7):666-74.

The Solution

The only fast and comprehensive SSTI test available:

  • Xpert® MRSA/SA SSTI is a fast, on-demand test for detecting MRSA and SA from skin and soft tissue swabs in around one hour
  • Xpert MRSA/SA SSTI is the most comprehensive Staph aureus test available:
    • Includes targets for Staph aureus, MRSA, and mecA
    • Identifies presumptive positive “empty cassette” strains for correct classification as SA sensitive
    • Unparalleled automation with the GeneXpert® System provides reduced hands-on time and improved laboratory efficiency

Important healthcare benefits of rapid detection:

  • Helps ensure the right therapy sooner for improved patient management
  • Enables a targeted antimicrobial therapy approach for better antimicrobial stewardship
  • Allows for immediate identification of patient infection for improved isolation and infection control measures

Ordering Info

Xpert® MRSA/SA SSTI

Number of Tests: 10

Catalog #: GXMRSA/SA-SSTI-10

Educational Materials

#carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
Limiting Inappropriate Antibiotic Use in the ED
VIDEO

Limiting Inappropriate Antibiotic Use in the ED

Dr. Larissa May discusses how clinical practice guidelines on skin and soft tissue infections make it more important than ever to use diagnostics to guide targeted antibiotic use. Hear how her institution was able to reduce inappropriate antibiotic use in the ED with the help of on-demand PCR testing for MRSA and S. aureus.

Ephraim McDowell Regional Medical Center
DOCUMENT

Ephraim McDowell Regional Medical Center

Ephraim McDowell Regional Medical Center improves adherence to optimized testing protocols for C. difficile resulting in lower C. difficile rates and decreased patient time in isolation.    

Webinar: Antibiotic Stewardship in the Emergency Department
WEBINAR

Webinar: Antibiotic Stewardship in the Emergency Department

This webinar will discuss the importance of diligent antimicrobial stewardship and accuracy of diagnostic tests for the detection of Group A Streptococcus pharyngitis. It will provide commentary on the high confidence that molecular testing affords the antibiotic steward and how the technology can reduce the practice of prescribing antibiotics "just-in-case" there is an infection, especially as testing moves closer to the patient.

Webinar: RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs
WEBINAR

Webinar: RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs

This webinar discusses data supporting the combination of rapid diagnostic tests (RDT) and antimicrobial stewardship programs (ASPs), reviews RDT systems, and provides guidance on how ASPs can implement and optimize the use of RDTs in virtually any healthcare setting.

White Paper: Preventing "Nightmare Bacteria" from&nbsp;Becoming Nightmare Outbreaks
DOCUMENT

White Paper: Preventing "Nightmare Bacteria" from Becoming Nightmare Outbreaks

In early 2015, carbapenem-resistant Enterobacteriaceae (CRE) became a household term when a high-profile outbreak — including two deaths — at a California hospital were linked to contaminated medical scopes.

White Paper: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance
DOCUMENT

White Paper: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance

CDC has declared the complex problem of AMR a serious threat today, which will result in potential catastrophic consequences with continued inaction. To combat AMR, the CDC has identified 4 core actions, all of which can be addressed through rapid molecular diagnostics:

Back to Top